Mallory E. Harden

Mallory E. Harden, PhD has a diverse work experience with a focus on business development and operations in the biotechnology and pharmaceutical sectors. Mallory is currently serving as the Senior Director | BD and Operations at CoA Therapeutics since February 2023. Prior to this role, Mallory held positions as the Director | BD and Operations and Manager | BD and Operations at the same company from January 2021 to January 2023 and May 2020 to December 2020, respectively.

In addition, Mallory has gained valuable experience at ML Bio Solutions, a Bridge Bio Company, where they worked as the Senior Director | BD and Operations from February 2023 onwards and as the Director | BD and Operations from September 2022 to January 2023.

Earlier in their career, Mallory worked at CardioVascular Resource Group, LLC. Mallory held the positions of Therapy Area Manager | Cardiovascular Diseases from March 2019 to May 2020 and Disease Area Manager | Cardiovascular Diseases from June 2017 to March 2019.

Mallory began their career as a TechAtlas Intern at RA Capital Management, LLC in June 2016, where they gained early exposure to the industry.

Throughout their career, Mallory has demonstrated their expertise in business development and operations, with a focus on cardiovascular diseases and biotechnology.

Mallory E. Harden, PhD holds a Doctor of Philosophy (PhD) in Virology from Harvard Medical School. Prior to that, they earned a Bachelor of Science (BS) with honors in Neuroscience, Magna Cum Laude from Trinity University.